S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSEAMERICAN:PTN

Palatin Technologies (PTN) News Today

$2.28
-0.02 (-0.87%)
(As of 06/9/2023 ET)
Compare
Today's Range
$2.25
$2.46
50-Day Range
$2.10
$3.10
52-Week Range
$2.08
$9.48
Volume
33,619 shs
Average Volume
76,983 shs
Market Capitalization
$25.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Get Palatin Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.



PTN Media Mentions By Week

PTN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTN
News Sentiment

0.00

0.70

Average
Medical
News Sentiment

PTN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTN Articles
This Week

0

1

PTN Articles
Average Week

SourceHeadline
uk.finance.yahoo.com logoPTN - Palatin Technologies, Inc.
uk.finance.yahoo.com - May 30 at 9:15 PM
finance.yahoo.com logoPalatin Presents Preclinical Diabetic Nephropathy Data at the International Podocyte Conference
finance.yahoo.com - May 30 at 8:29 AM
MarketBeat logoPalatin Technologies (NYSEAMERICAN:PTN) Downgraded to Sell at StockNews.com
americanbankingnews.com - May 21 at 1:54 AM
MarketBeat logoPalatin Technologies (NYSEAMERICAN:PTN) Announces Earnings Results, Misses Estimates By $0.24 EPS
americanbankingnews.com - May 19 at 9:49 AM
MarketBeat logoPalatin Technologies (NYSE:PTN) Now Covered by Analysts at StockNews.com
americanbankingnews.com - May 19 at 6:36 AM
finance.yahoo.com logoPalatin Technologies, Inc. (AMEX:PTN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - May 17 at 3:11 PM
finance.yahoo.com logoQ3 2023 Palatin Technologies Inc Earnings Call
finance.yahoo.com - May 17 at 2:03 AM
markets.businessinsider.com logoLadenburg Thalmann & Co. Sticks to Its Buy Rating for Palatin Technologies (PTN)
markets.businessinsider.com - May 16 at 2:54 PM
markets.businessinsider.com logoPalatin Technologies (PTN) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - May 16 at 2:11 PM
finance.yahoo.com logoPalatin Technologies, Inc. (PTN) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - May 16 at 10:30 AM
markets.businessinsider.com logoPalatin Technologies Inc. Q3 Loss Narrows
markets.businessinsider.com - May 16 at 9:11 AM
finance.yahoo.com logoPalatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - May 16 at 9:11 AM
msn.com logoHC Wainwright & Co. Reiterates Palatin Technologies (PTN) Buy Recommendation
msn.com - May 11 at 7:29 PM
finance.yahoo.com logoTELA Bio, Inc. (TELA) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 11 at 7:29 PM
finance.yahoo.com logoPalatin to Report Third Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on May 16, 2023
finance.yahoo.com - May 11 at 6:05 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and DermTech (DMTK)
markets.businessinsider.com - May 9 at 8:29 AM
finance.yahoo.com logoPalatin Presents PL8177 Ulcerative Colitis Data at Digestive Disease Week Annual Conference
finance.yahoo.com - May 9 at 8:29 AM
finance.yahoo.com logoPalatin Invites Investors to Listen to Replay of the PL9643 Dry Eye Disease Key Opinion Leader Webinar
finance.yahoo.com - May 8 at 6:24 PM
finance.yahoo.com logoPalatin Technologies to Host Key Opinion Leader Webinar
finance.yahoo.com - May 1 at 5:40 PM
markets.businessinsider.com logoLadenburg Thalmann & Co. Keeps Their Buy Rating on Palatin Technologies (PTN)
markets.businessinsider.com - May 1 at 7:39 AM
finance.yahoo.com logoPalatin Presents Initial Dry Eye Disease Phase 3 Clinical Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference
finance.yahoo.com - April 27 at 9:37 AM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Palatin Technologies (PTN)
markets.businessinsider.com - April 25 at 4:06 PM
finance.yahoo.com logoPalatin Presents Data at the Association of Research in Vision and Ophthalmology 2023 Annual Conference Regarding a Potential Treatment for Glaucoma
finance.yahoo.com - April 25 at 7:41 AM
finance.yahoo.com logoPalatin Announces Preliminary Third Quarter Fiscal 2023 Vyleesi® Product Revenue Results
finance.yahoo.com - April 19 at 9:47 AM
MarketBeat logoCV Sciences (OTCMKTS:CVSI) & (NYSE:PTN) Financial Comparison
americanbankingnews.com - April 19 at 3:30 AM
finance.yahoo.com logoPre-Clinical Data of Palatin's Melanocortin Agonist Demonstrating Therapeutic Effects in Diabetic Retinopathy and Uveitis Published in the International Journal of Molecular Sciences
finance.yahoo.com - April 18 at 8:12 AM
MarketBeat logoPalatin Technologies (NYSE:PTN) Shares Up 2.2%
americanbankingnews.com - April 9 at 3:30 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Palatin Technologies (PTN), Stryker (SYK)
markets.businessinsider.com - March 13 at 5:37 PM
finance.yahoo.com logoFrontiers in Immunology Publishes Pre-Clinical Study of Palatin's Oral Formulation of PL8177 Demonstrating Therapeutic Effects in Inflammatory Bowel Disease
finance.yahoo.com - March 2 at 9:30 AM
markets.businessinsider.com logoPalatin Technologies Says USPTO Issues Patent On Vyleesi For Hypoactive Sexual Desire Disorder
markets.businessinsider.com - February 28 at 9:58 AM
finance.yahoo.com logoPalatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension
finance.yahoo.com - February 28 at 8:10 AM
benzinga.com logoPalatin Technologies Earnings Perspective: Return On Capital Employed
benzinga.com - February 16 at 10:39 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Lantheus (LNTH)
markets.businessinsider.com - February 15 at 2:51 PM
finance.yahoo.com logoPalatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - February 15 at 9:50 AM
msn.com logoEarnings Outlook For Palatin Technologies
msn.com - February 14 at 3:58 PM
finance.yahoo.com logoPalatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023
finance.yahoo.com - February 10 at 8:46 AM
finance.yahoo.com logoMyovant Sciences (MYOV) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - January 26 at 7:03 PM
msn.com logoPalatin starts mid-stage study of bremelanotide for diabetic kidney disease
msn.com - January 19 at 1:56 PM
finance.yahoo.com logoPalatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease
finance.yahoo.com - January 19 at 7:36 AM
marketwatch.com logoPalatin Technologies Shares Jump on $4.7 Million Funding News
marketwatch.com - January 18 at 9:36 PM
finance.yahoo.com logoPalatin Receives $4.7 Million of Non-Dilutive Funding
finance.yahoo.com - January 18 at 7:38 AM
finance.yahoo.com logoFrontiers in Immunology Publishes Pre-Clinical Study of Palatin's PL8177 Demonstrating Therapeutic Effects in Inflammatory Conditions
finance.yahoo.com - January 10 at 8:02 AM
finance.yahoo.com logoPalatin Announces Preliminary Second Quarter Fiscal 2023 Vyleesi® Product Sales Results
finance.yahoo.com - January 5 at 7:43 AM
thestreet.com logoPalatin Technologies (PTN) Stock Spikes Following FDA Approval of 'Female Viagra' Treatment
thestreet.com - January 5 at 12:12 AM
benzinga.com logoPalatin Technologies's Return On Capital Employed Insights
benzinga.com - December 23 at 2:37 PM
seekingalpha.com logoPalatin Technologies, Inc. (PTN) Q1 2023 Earnings Call Transcript
seekingalpha.com - November 14 at 2:29 PM
finance.yahoo.com logoPalatin Technologies, Inc. (PTN) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - November 14 at 12:09 PM
markets.businessinsider.com logoPalatin Technologies Inc. Q1 Loss increases, but beats estimates
markets.businessinsider.com - November 14 at 9:29 AM
finance.yahoo.com logoPalatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 14 at 9:29 AM
finance.yahoo.com logoSolid Biosciences Inc. (SLDB) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 10 at 12:22 PM
Get Palatin Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSEAMERICAN:PTN) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -